Articles By RheumNow
Immunophysiology of the Gout Attack
By RheumNow
Gout may be an ancient disease, with arthritis of the big toe having been described in Egypt in 2,600 BC, but only now are the underlying pathophysiologic events being elucidated and understood.
Read Article
Nailfold Capillary Density Predicts Dermatomyositis Lung Involvement
By RheumNow
In patients with juvenile dermatomyositis (DM), an association was seen between low nailfold capillary density and pulmonary involvement, European researchers reported.
Read Article
Systemic Sclerosis: More Common than Expected
By RheumNow
Systemic sclerosis is more common in the United Kingdom than previously reported, a nationwide population-based study determined.
Read Article
Does RA Have a Prodrome?
By RheumNow
A pattern of increased primary care visits and joint complaints during the 2 years before rheumatoid arthritis (RA) was diagnosed were predictive of the diagnosis, a British case-control study found.
Read Article
NPF Dietary Recommendations for Psoriatic Disease
By RheumNow
The National Psoriasis Foundation has released dietary recommendations for adults with psoriasis and psoriatic arthritis, based on a systematic review of the current literature, with the strongest focus on weight reduction for those who are overweight or obese.
Read Article
Enthesitis in PsA: A New Focus of Treatment?
By RheumNow
Patients with psoriatic arthritis (PsA) whose disease manifestations include enthesitis showed significantly greater responses to interleukin (IL)-23 inhibition than to blocking tumor necrosis factor (TNF), suggesting the possibility that treatment decisions in the future might be guided by speci
Read Article
Abatacept Misses in Lupus Nephritis
By RheumNow
Dr. Richard Furie, MD, of Northwell Health in New York, presented the findings ofa large phase III trial of abatacept (Orencia) in lupus nephritis showing the agent failed to achieve a complete renal response.
Read Article
Blacks Suffer When Pain is Poorly Defined
By RheumNow
Racial discrimination was a key feature at a 2-day summit on pain management and the opioid crisis, hosted by the National Institutes of Health on Thursday and Friday.
Read Article
Ustekinumab: A Novel Intervention in Giant Cell Arteritis
By RheumNow
Treatment of refractory giant cell arteritis (GCA) with ustekinumab (Stelara) showed therapeutic promise as a steroid-sparing agent in a small, open-label study, Irish researchers reported.
Read Article
High anti-TNF Failure Rates with Obesity
By RheumNow
A meta-analysis has suggested that obesity is an under-reported predictor of inferior response to tumor necrosis factor blockade (anti-TNF) in a range of inflammatory immune-mediated inflammatory diseases (IMIDs), with the results showing a 60% risk of impaired response to anti-TNF across several
Read Article